Archives
-
5-hme-dCTP for DNA Hydroxymethylation Assays
2026-09-02
5-hme-dCTP gives researchers a defined DNA polymerase substrate for building hydroxymethylated controls, testing assay performance, and studying epigenetic DNA modification. Its greatest value is as a workflow-enabling reagent for low-abundance 5hmC measurements, including plant drought response epigenetics, rather than as a stand-alone detector of native DNA marks.
-
RCN2 Links ESCC Metastasis to Cisplatin Resistance
2026-09-02
This study identifies reticulocalbin 2 (RCN2) as a mechanistic driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance. Its central finding is that RCN2 promotes UBR5-dependent PPP2CA ubiquitination and degradation, activating PI3K–AKT signaling and exposing a potential vulnerability for combination treatment.
-
Liproxstatin-1 HCl Ferroptosis Workflows
2026-09-01
Liproxstatin-1 HCl provides a selective way to confirm ferroptotic lipid damage in cellular and organ-injury research. This practical guide connects nanomolar inhibition with assay design, mitochondrial calcium biology, acute renal failure models, hepatic ischemia/reperfusion injury, and troubleshooting strategies.
-
EZ Cap™ Mouse IL-12 mRNA Workflow
2026-09-01
A bench-ready guide to using EZ Cap™ Mouse IL-12 mRNA (m1Ψ) for cytokine expression, T-cell and NK-cell assay development, and delivery-platform testing. It connects practical handling and optimization with evidence from an extrahepatic virus-mimicking particle study, while separating validated findings from assay-development recommendations.
-
Hyaluronic Acid Sodium Salt for siRNA Nanoparticles
2026-08-31
Hyaluronic acid sodium salt helps researchers connect extracellular-matrix modeling with targeted siRNA nanoparticle workflows. Its high-molecular-weight, anionic profile supports coating optimization, immune-cell assays, organoid studies, and troubleshooting of nanoparticle–cell interactions.
-
WAY-100635: A Receptor-Logic Framework
2026-08-31
WAY-100635 enables selective interrogation of 5-HT1A signaling across binding, behavioral, and imaging experiments. This article develops an assay-decision framework linking receptor pharmacology with emerging evidence on pain, affect, and serotonergic circuit activity.
-
iRhom2 in Olfaction: Receptor Regulation and Adaptation
2026-08-30
Azzopardi and colleagues identify iRhom2 as a distinctive component of olfactory sensory neurons and link its expression to odorant receptor regulation and activity-dependent adaptation. Combining knockout mice, transcriptomics, spatial validation, and heterologous receptor signaling, the study proposes an iRhom2–ADAM17 pathway that may connect odor stimulation with feedback control of olfactory gene expression.
-
DAF-2 Diacetate for Nitric Oxide Imaging
2026-08-29
DAF-2 diacetate, also called 4,5-Diaminofluorescein diacetate, is a cell-permeable fluorescent probe for intracellular nitric oxide measurement. Its esterase-activated signal supports live-cell nitric oxide imaging and provides a practical readout for NO-related processes in soybean nodule senescence research.
-
Cyclosporin A: Assay Design and Workflows
2026-08-28
Cyclosporin A provides a reversible way to probe cyclophilin–calcineurin signaling, T-cell suppression, and mitochondrial permeability transition. This guide converts its mechanism into practical dose-finding, mitochondrial, immunology, and neuroscience workflows while clearly separating established findings from assay extensions.
-
O6-Benzylguanine: MGMT Inhibitor Guide
2026-08-28
O6-Benzylguanine is a potent MGMT inhibitor used to study DNA repair inhibition and sensitization to alkylating agents. The compound irreversibly inactivates MGMT, but its experimental effects depend on cell model, alkylating-agent context, exposure design, and validated controls.
-
Dual-Loaded Liposome Encapsulation Efficiency
2026-08-27
Tong Yuan and colleagues compared separation workflows for measuring encapsulation efficiency in liposomes carrying hydrophilic and lipophilic drugs, with particular attention to doxorubicin hydrochloride-containing formulations. Their validated nanoparticle exclusion chromatography–HPLC approach enabled simultaneous analysis without pretreatment and was more broadly applicable than centrifugation- or PEG-dependent alternatives.
-
SM-102 for mRNA Delivery: Practical Workflow
2026-08-27
SM-102 provides a practical ionizable-lipid starting point for LNP-based mRNA delivery, from fresh ethanol stock preparation to cell-based potency testing. This workflow combines product-specific handling, controlled N/P screening, orthogonal assays, and machine-learning insights to reduce avoidable formulation errors.
-
Topotecan Pharmacology and Clinical Evidence
2026-08-26
The 1999 review by Kollmannsberger and colleagues integrated topotecan’s topoisomerase I mechanism with its pharmacokinetics, toxicity profile, dosing strategies, and early clinical activity. Its main contribution was to show how lactone chemistry, renal elimination, schedule dependence, and limited cross-resistance shaped the translational development of this camptothecin analogue.
-
Dihydrotestosterone Workflows for AR Research
2026-08-26
Build reproducible DHT assays around androgen receptor signaling, EGFR–ERBB2 pathway crosstalk, and muscle phenotyping in ALS models. This practical guide also shows how the nutrient-restriction and retinoic-acid strategy from a mouse SSC study can inform assay design without overstating evidence for DHT in meiotic induction.
-
Phillygenin Mechanisms in Diabetic Nephropathy
2026-08-25
The reference study shows that phillygenin protects against diabetic nephropathy in high-glucose podocytes and db/db mice by suppressing TLR4/MyD88/NF-κB-associated inflammation and apoptosis while restoring PI3K/AKT/GSK3β signaling. Its integrated use of RNA sequencing, molecular validation, and renal phenotyping provides a mechanistic framework for evaluating phillygenin, although translation beyond experimental models remains unresolved.